<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03741439</url>
  </required_header>
  <id_info>
    <org_study_id>Marconi01</org_study_id>
    <nct_id>NCT03741439</nct_id>
  </id_info>
  <brief_title>RCTrial to Test Low Intensity Shockwave Treatment in Patients With Mild/Moderate Erectile Dysfunction</brief_title>
  <official_title>Randomized Controlled Trial to Test Low Intensity Shockwave Treatment in Patients With Mild and Moderate Erectile Dysfunction Using a Electromagnetic Emitter</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Santiago de Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Chile</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IVI Santiago de Chile</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Even though, the efficacy of Low-Intensity Shockwave Therapy (LIST) to treat Erectile
      Dysfunction (ED) has been documented by numerous trials; it is still not recommended by
      clinical guidelines. Different types of: shockwave generators, treatment protocols and ED
      severities of patients included in the studies, explain the lack of recommendations for a
      standard treatment. Ideally, each shockwave generator should have its own efficacy data from
      randomized controlled trials, using standardized protocols, and in defined populations.

      Objective: to test the efficacy of a electromagnetic shockwave generator (Dornier Aries) in
      treating patients with mild and moderate ED in a randomized controlled trial.

      Patients and methods: 38 patients with mild/moderate ED (IIEF-5= 11-21), are being
      prospectively randomized (1:1) to receive 6 sessions of LIST or sham (same: number of
      sessions, time and sound, with out transmitting energy). The patients and who analyzed the
      data are blind to randomization. The following parameters were analyzed: IIEF-5, IIEF-15,
      Sexual Encounter Profile (SEP) 2 and 3, Global Assessment Question (GAQ) 1 and Erection
      Hardness Score (EHS) at: baseline (T0), at the end of the 6 sessions (T1); at 6 (T2) and 12
      weeks (T3). During all the study patients were instructed to receive no other treatment for
      ED.

      After ending T3 we expect to treat placebo patients to see impact of changing arm study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We are test the efficacy of a electromagnetic shockwave generator (Dornier Aries) in treating
      patients with mild and moderate ED in a randomized controlled trial.

      Patients and methods: 38 patients with mild/moderate ED (IIEF-5= 11-21), are being
      prospectively randomized (1:1) to receive 6 sessions of LIST or sham (same: number of
      sessions, time and sound, with out transmitting energy). The patients and who analyzed the
      data are blind to randomization. The following parameters were analyzed: IIEF-5, IIEF-15,
      Sexual Encounter Profile (SEP) 2 and 3, Global Assessment Question (GAQ) 1 and Erection
      Hardness Score (EHS) at: baseline (T0), at the end of the 6 sessions (T1); at 6 (T2) and 12
      weeks (T3). During all the study patients were instructed to receive no other treatment for
      ED.

      After ending T3 we expect to treat placebo patients to see impact of changing arm study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 17, 2018</start_date>
  <completion_date type="Anticipated">January 2, 2019</completion_date>
  <primary_completion_date type="Actual">November 2, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Patients and who analyzes the data are blind to randomization.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in IIEF-5</measure>
    <time_frame>12 weeks</time_frame>
    <description>We expect a change of 3.5 points in the IIEF-5 score</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">38</enrollment>
  <condition>Erectile Dysfunction</condition>
  <condition>Endothelial Dysfunction</condition>
  <arm_group>
    <arm_group_label>Treatment arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receives real treatment according to manufactures instructions. 6 sessions of low intensity shockwave treatment with an electromagnetic emitter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Arm</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Receives sham treatment with same applicator, same sound, same time and number of shocks. But no real energy is delivered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Treatment</intervention_name>
    <description>Low intensity shockwave treatment in patients with mild/moderate ED using a electromagnetic emitter</description>
    <arm_group_label>Treatment arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>Sham treatment</description>
    <arm_group_label>Sham Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mild/moderate erectile dysfunction

          -  Good response to any phospodiesterase inhibitor

        Exclusion Criteria:

          -  No history of erectile dysfunction

          -  No decompensated diabetes

          -  No untreated hypogonadism

          -  No severe erectile dysfunction
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only men because is for erectile dysfunction.</gender_description>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcelo Marconi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asistant Professor Urology Department Universidad Catolica de Chile</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marcelo Marconi, MD</last_name>
    <phone>+56979685115</phone>
    <email>mmarconi@andro.cl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marcelo Marconi, MD</last_name>
    <phone>+56979685115</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Unidad de Andrologia - Red Salud UC/Christus</name>
      <address>
        <city>Santiago</city>
        <state>Region Metropolitana</state>
        <zip>RM</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcelo Marconi, MD</last_name>
      <phone>+56979685115</phone>
      <email>mmarconi@andro.cl</email>
    </contact>
    <contact_backup>
      <last_name>Marcelo Marconi, MD</last_name>
      <phone>+56979685115</phone>
      <email>info@andro.cl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 11, 2018</study_first_submitted>
  <study_first_submitted_qc>November 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2018</study_first_posted>
  <last_update_submitted>November 11, 2018</last_update_submitted>
  <last_update_submitted_qc>November 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>We are evaluating is we decide to share all the protocol. All the protocol will be published with the results.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

